Global Primary Biliary Cirrhosis Drug Market Analysis 2016-2020 and Forecast 2021-2026
Global Primary Biliary Cirrhosis Drug Market Analysis 2016-2020 and Forecast 2021-2026
The Primary Biliary Cirrhosis Drug Market report highlights technological advancements, investment opportunities, and regulatory frameworks shaping the industry landscape through 2030.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The global Primary Biliary Cirrhosis Drug market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Primary Biliary Cirrhosis Drug by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Budesonide
FFP-104
GSK-2330672
MBX-8025
NGM-282
Others
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
AlbireoPharma
CymaBay Therapeutics, Inc.
Dr. Falk Pharma GmbH
Enanta Pharmaceuticals, Inc.
GlaxoSmithKline Plc
Intercept Pharmaceuticals, Inc.
Johnson & Johnson
MediGene AG
NGM Biopharmaceuticals, Inc.
Virobay Inc.
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Clinic
Hospital
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
1 Industry Overview
1.1 Primary Biliary Cirrhosis Drug Industry
Figure Primary Biliary Cirrhosis Drug Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Primary Biliary Cirrhosis Drug
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Primary Biliary Cirrhosis Drug
1.2.2 Downstream
Table Application Segment of Primary Biliary Cirrhosis Drug
Table Global Primary Biliary Cirrhosis Drug Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Primary Biliary Cirrhosis Drug Market by Type
3.1 By Type
3.1.1 Budesonide
Table Major Company List of Budesonide
3.1.2 FFP-104
Table Major Company List of FFP-104
3.1.3 GSK-2330672
Table Major Company List of GSK-2330672
3.1.4 MBX-8025
Table Major Company List of MBX-8025
3.1.5 NGM-282
Table Major Company List of NGM-282
3.1.6 Others
Table Major Company List of Others
3.2 Market Size
Table Global Primary Biliary Cirrhosis Drug Market 2016-2020, by Type, in USD Million
Figure Global Primary Biliary Cirrhosis Drug Market Growth 2016-2020, by Type, in USD Million
Table Global Primary Biliary Cirrhosis Drug Market 2016-2020, by Type, in Volume
Figure Global Primary Biliary Cirrhosis Drug Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Primary Biliary Cirrhosis Drug Market Forecast 2021-2026, by Type, in USD Million
Table Global Primary Biliary Cirrhosis Drug Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 AlbireoPharma (Company Profile, Sales Data etc.)
4.1.1 AlbireoPharma Profile
Table AlbireoPharma Overview List
4.1.2 AlbireoPharma Products & Services
4.1.3 AlbireoPharma Business Operation Conditions
Table Business Operation of AlbireoPharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 CymaBay Therapeutics, Inc. (Company Profile, Sales Data etc.)
4.2.1 CymaBay Therapeutics, Inc. Profile
Table CymaBay Therapeutics, Inc. Overview List
4.2.2 CymaBay Therapeutics, Inc. Products & Services
4.2.3 CymaBay Therapeutics, Inc. Business Operation Conditions
Table Business Operation of CymaBay Therapeutics, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Dr. Falk Pharma GmbH (Company Profile, Sales Data etc.)
4.3.1 Dr. Falk Pharma GmbH Profile
Table Dr. Falk Pharma GmbH Overview List
4.3.2 Dr. Falk Pharma GmbH Products & Services
4.3.3 Dr. Falk Pharma GmbH Business Operation Conditions
Table Business Operation of Dr. Falk Pharma GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Enanta Pharmaceuticals, Inc. (Company Profile, Sales Data etc.)
4.4.1 Enanta Pharmaceuticals, Inc. Profile
Table Enanta Pharmaceuticals, Inc. Overview List
4.4.2 Enanta Pharmaceuticals, Inc. Products & Services
4.4.3 Enanta Pharmaceuticals, Inc. Business Operation Conditions
Table Business Operation of Enanta Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 GlaxoSmithKline Plc (Company Profile, Sales Data etc.)
4.5.1 GlaxoSmithKline Plc Profile
Table GlaxoSmithKline Plc Overview List
4.5.2 GlaxoSmithKline Plc Products & Services
4.5.3 GlaxoSmithKline Plc Business Operation Conditions
Table Business Operation of GlaxoSmithKline Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Intercept Pharmaceuticals, Inc. (Company Profile, Sales Data etc.)
4.6.1 Intercept Pharmaceuticals, Inc. Profile
Table Intercept Pharmaceuticals, Inc. Overview List
4.6.2 Intercept Pharmaceuticals, Inc. Products & Services
4.6.3 Intercept Pharmaceuticals, Inc. Business Operation Conditions
Table Business Operation of Intercept Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Johnson & Johnson (Company Profile, Sales Data etc.)
4.7.1 Johnson & Johnson Profile
Table Johnson & Johnson Overview List
4.7.2 Johnson & Johnson Products & Services
4.7.3 Johnson & Johnson Business Operation Conditions
Table Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 MediGene AG (Company Profile, Sales Data etc.)
4.8.1 MediGene AG Profile
Table MediGene AG Overview List
4.8.2 MediGene AG Products & Services
4.8.3 MediGene AG Business Operation Conditions
Table Business Operation of MediGene AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 NGM Biopharmaceuticals, Inc. (Company Profile, Sales Data etc.)
4.9.1 NGM Biopharmaceuticals, Inc. Profile
Table NGM Biopharmaceuticals, Inc. Overview List
4.9.2 NGM Biopharmaceuticals, Inc. Products & Services
4.9.3 NGM Biopharmaceuticals, Inc. Business Operation Conditions
Table Business Operation of NGM Biopharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Virobay Inc. (Company Profile, Sales Data etc.)
4.10.1 Virobay Inc. Profile
Table Virobay Inc. Overview List
4.10.2 Virobay Inc. Products & Services
4.10.3 Virobay Inc. Business Operation Conditions
Table Business Operation of Virobay Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Primary Biliary Cirrhosis Drug Sales Revenue 2016-2020, by Company, in USD Million
Table Global Primary Biliary Cirrhosis Drug Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Primary Biliary Cirrhosis Drug Sales Revenue Share in 2020, by Company, in USD Million
Table Global Primary Biliary Cirrhosis Drug Sales Volume 2016-2020, by Company, in Volume
Table Global Primary Biliary Cirrhosis Drug Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Primary Biliary Cirrhosis Drug Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Primary Biliary Cirrhosis Drug Market Concentration, in 2020
Figure Europe Primary Biliary Cirrhosis Drug Market Market Concentration, in 2020
Figure Asia-Pacific Primary Biliary Cirrhosis Drug MMarket Concentration, in 2020
Figure South America Primary Biliary Cirrhosis Drug Market Concentration, in 2020
Figure Middle East & Africa Primary Biliary Cirrhosis Drug Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Clinic
Figure Primary Biliary Cirrhosis Drug Demand in Clinic, 2016-2020, in USD Million
Figure Primary Biliary Cirrhosis Drug Demand in Clinic, 2016-2020, in Volume
6.1.2 Demand in Hospital
Figure Primary Biliary Cirrhosis Drug Demand in Hospital, 2016-2020, in USD Million
Figure Primary Biliary Cirrhosis Drug Demand in Hospital, 2016-2020, in Volume
6.1.3 Demand in Others
Figure Primary Biliary Cirrhosis Drug Demand in Others, 2016-2020, in USD Million
Figure Primary Biliary Cirrhosis Drug Demand in Others, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Primary Biliary Cirrhosis Drug Demand Forecast 2021-2026, by Application, in USD Million
Figure Primary Biliary Cirrhosis Drug Market Growth 2021-2026, by Application, in USD Million
Figure Primary Biliary Cirrhosis Drug Market Share in 2026, by Application, in USD Million
Table Primary Biliary Cirrhosis Drug Demand Forecast 2021-2026, by Application, in Volume
Table Primary Biliary Cirrhosis Drug Market Growth 2021-2026, by Application, in Volume
Table Primary Biliary Cirrhosis Drug Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Primary Biliary Cirrhosis Drug Production 2016-2020, by Region, in USD Million
Table Primary Biliary Cirrhosis Drug Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Primary Biliary Cirrhosis Drug Market 2016-2020, by Region, in USD Million
Table Global Primary Biliary Cirrhosis Drug Market Share 2016-2020, by Region, in USD Million
Table Global Primary Biliary Cirrhosis Drug Market 2016-2020, by Region, in Volume
Table Global Primary Biliary Cirrhosis Drug Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Primary Biliary Cirrhosis Drug Market Size and Growth 2016-2020, in USD Million
Figure North America Primary Biliary Cirrhosis Drug Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in USD Million
Table North America Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Primary Biliary Cirrhosis Drug Market Size and Growth 2016-2020, in USD Million
Figure Europe Primary Biliary Cirrhosis Drug Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in USD Million
Table Europe Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Primary Biliary Cirrhosis Drug Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Primary Biliary Cirrhosis Drug Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Primary Biliary Cirrhosis Drug Market Size and Growth 2016-2020, in USD Million
Figure South America Primary Biliary Cirrhosis Drug Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in USD Million
Table South America Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Primary Biliary Cirrhosis Drug Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Primary Biliary Cirrhosis Drug Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Primary Biliary Cirrhosis Drug Market Forecast 2021-2026, by Region, in USD Million
Table Primary Biliary Cirrhosis Drug Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
Research Methodology:
Primary Biliary Cirrhosis Drug Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|